Fyteko
The company develops bio-based plant protection products and biostimulants using proprietary signal molecules derived from hydroxycinnamic acid oligomers. Its primary products, NURSEED and NURSPRAY, are designed for seed treatment and foliar application to enhance crop resilience against abiotic stresses like drought and heat. These solutions target the global agricultural market, specifically for high cash and row crops, to reduce reliance on conventional chemical inputs.
Visit websiteBrussels, Belgium
Agritech
Biotechnology
Climate Tech
Sustainable Agriculture
Funding summary
- Total raised
- €13.5M
- Funding rounds
- 2
Investors in Fyteko
Investors on record for Fyteko. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Fyteko?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors